Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Analysts' Top Healthcare Picks: Lifecore Biomedical (LFCR), Castle Biosciences (CSTL)
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $10
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Barrington Remains a Hold on Lifecore Biomedical (LFCR)
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $8
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Lifecore Biomedical: A Cautious Hold Amid Modest Growth and Financial Challenges
Craig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)
Stephens Maintains Lifecore Biomedical(LFCR.US) With Hold Rating, Cuts Target Price to $5
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Lifecore Biomedical Analyst Ratings
Craig-Hallum Initiates Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $8
Barrington Downgrades Lifecore Biomedical(LFCR.US) to Hold Rating
Stephens & Co. Maintains Equal-Weight on Lifecore Biomedical, Raises Price Target to $9